United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Astrocyte Pharmaceuticals secures over $6m for brain injury treatments Astrocyte Pharmaceuticals Inc., a vanguard in the realm of cerebroprotective drug discovery, has amassed over $6 million in… byPallavi MadhirajuAugust 20, 2023